Amevive and Dry skin - a phase IV clinical study of FDA data

Summary:

Dry skin is reported as a side effect among people who take Amevive (alefacept), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cosentyx,.

The phase IV clinical study analyzes which people have Dry skin when taking Amevive. It is created by eHealthMe based on reports of 3,807 people who have side effects when taking Amevive from the FDA, and is updated regularly.

What is Amevive?

Amevive has active ingredients of alefacept. It is often used in psoriasis. eHealthMe is studying from 3,812 Amevive users. Check the latest studies of Amevive.

What is Dry skin?

Dry skin is found to be associated with 1,991 drugs and 2,353 conditions by eHealthMe. Check the latest studies of Dry skin.



On Jul, 08, 2026

3,807 people reported to have side effects when taking Amevive.
Among them, 15 people (0.39%) have Dry skin.

Could Amevive cause Dry skin?

Among these 15 people:

How long have people been on Amevive when they have Dry skin? *

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

What is the gender of people who have Dry skin when taking Amevive? *

  • female: 73.33 %
  • male: 26.67 %

What is the age of people who have Dry skin when taking Amevive? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 18.18 %
  • 40-49: 27.27 %
  • 50-59: 18.18 %
  • 60+: 36.36 %

What are other drugs people take besides Amevive? *

  1. Stelara: 4 people, 26.67%
  2. Otezla: 4 people, 26.67%
  3. Cosentyx: 4 people, 26.67%
  4. Vancomycin Hydrochloride: 1 person, 6.67%
  5. Toprol-Xl: 1 person, 6.67%
  6. Neoral: 1 person, 6.67%
  7. Lasix: 1 person, 6.67%
  8. Diprolene: 1 person, 6.67%
  9. Clobetasol Propionate: 1 person, 6.67%
  10. Calcipotriene And Betamethasone Dipropionate: 1 person, 6.67%

What are other side effects people have besides Dry skin? *

  1. Itching: 7 people, 46.67%
  2. Rashes (redness): 7 people, 46.67%
  3. Influenza Like Illness: 5 people, 33.33%
  4. Drug Ineffective: 5 people, 33.33%
  5. Pain Of Skin: 5 people, 33.33%
  6. Seborrheic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 4 people, 26.67%
  7. Pain: 4 people, 26.67%
  8. Joint Pain: 4 people, 26.67%
  9. Migraine (headache): 4 people, 26.67%
  10. Varicose Vein (veins that have become enlarged and tortuous): 4 people, 26.67%

* Approximation only. Some reports may have incomplete information.

Do you take Amevive and have Dry skin?

- Check whether Dry skin is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, long term effects of, and alternative drugs to Amevive:

Dry skin treatments and more:

How severe was Dry skin and when was it recovered:

Expand to all the drugs that have ingredients of alefacept:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amevive:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dry skin:

Browse all the conditions that are associated with Dry skin:


How the study uses the data?

The study uses data from the FDA. It is based on alefacept (the active ingredients of Amevive) and Amevive (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: